Britannia Pharmaceuticals Ltd

About Britannia Pharmaceuticals Ltd

A UK-based pharmaceutical company specializing in neurology, focusing on innovative products for Parkinson's disease treatment to improve patients' quality of life

Key facts

Industry

Pharmaceutical Manufacturing

Company size

51–250 employees

Headquarters

reading, berkshire, United Kingdom

Founded

1981

Revenue

£86.5MFY2024, publicly reported

Website

britannia-pharm.co.uk

LinkedIn

linkedin.com/company/britannia-pharmaceuticals-ltd

Britannia Pharmaceuticals Ltd in the news

• Reading firm recognised as a top employer

  All STADA UK entities, including Britannia Pharmaceuticals, have received Top Employer accreditation for their HR practices and commitment to employee wellbeing.

  readingchronicle.co.uk · Jan 17, 2025
• Challenges of equitable access to device-aided therapies for advanced Parkinson’s Disease in Poland — expert consensus and treatment recommendations | Popławska-Domaszewicz | Neurologia i Neurochirurgia Polska

  Polish experts recommend improving patient access to modern infusion pumps and subcutaneous apomorphine to address gaps in advanced Parkinson’s Disease care.

  journals.viamedica.pl · Dec 27, 2024
• A new paradigm for Parkinson’s treatment in Ireland

  Lecigon, a new intestinal gel for advanced Parkinson's disease, has been launched and reimbursed in Ireland by Britannia Pharmaceuticals Ltd.

  imt.ie · Dec 6, 2022
• Medica Hospital, Kings College and Britannia Pharmaceuticals collaborate

  Medica Superspecialty Hospital, in partnership with Kings College London and Britannia Pharmaceuticals, launched a new Parkinson's disease treatment, 'Apomorphine Pen and Pump,' in eastern India.

  expresshealthcare.in · Jan 7, 2019
• New Parkinson's treatment launches in India

  Vikram Hospital and Britannia Pharmaceuticals have introduced Apomorphine injections and pumps to India to treat middle-stage Parkinson's disease.

  biospectrumasia.com · Dec 6, 2018